Ranitidine Hcl SIDE EFFECTS,Cas no.66357-35-5, api lists in India,exporters, importers, manufacturers, suppliers, buyers, side Effects, Interactions, Information, tramadol, Overdosage, Ranitidine Hcl Powder,

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Ranitidine hydrochlorideis a histamine H2-receptor antagonist that inhibits stomach acid production.

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Ranitidine Hydrochloride Manufacturers in India Suppliers Ranitidine Hydrochloride Exporters Distributors Ranitidine Hydrochloride api active pharmaceuticals ingredients Ranitidine Hydrochloride manufacturers Side Effects bulk drugs raw material Ranitidine Hydrochloride companies Side Effects Importers Ranitidine Hydrochloride Ranitidine Hydrochloride Exporters Ranitidine Hydrochloride exporters FDA Ranitidine Hydrochloride DMF Symptoms Generic Taj Pharmaceuticals Ltd.

Pharmaceuticals API Manufacturer Ranitidine Hydrochloride, Ranitidine Hydrochloride manufacturer India, Ranitidine Hydrochloride product, Ranitidine Hydrochloride products, Api preparation, Certificate of Analysis API manufacturer product, Ranitidine Hydrochloride anti ulcer product, Certificate of Origin COA Ranitidine Hydrochloride COS Ranitidine Hydrochloride, pharmaceutical generic, pharmaceutical drug, medical, Ranitidine Hydrochloride pharma healthcare, pharma patents, contract MSDS manufacturing Trader Ranitidine Hydrochloride pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Ranitidine Hydrochloride expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Ranitidine Hydrochloride DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Ranitidine Hydrochloride ingredients, api, HIV Ranitidine Hydrochloride, tablets, capsules, syrup & protein Ranitidine Hydrochloride powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Ranitidine Hydrochloride gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Ranitidine Hydrochloride WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API
	Pharmaceuticals API List >>
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

HOME >> API >> API List 3 >> Ranitidine Hydrochloride >> Side Effects

SIDE EFFECTS
Ranitidine Hydrochloride CAS number 66357-35-5

Ranitidine may cause side effects

* headache
* dizziness
* constipation
* diarrhea
* stomach pain
* upset stomach

Central Nervous System: Rarely, malaise, dizziness, somnolence, insomnia, and vertigo. Rare cases of reversible mental confusion, agitation, depression, and hallucinations have been reported, predominantly in severely ill elderly patients. Rare cases of reversible blurred vision suggestive of a change in accommodation have been reported. Rare reports of reversible involuntary motor disturbances have been received.

Cardiovascular: As with other H2-blockers, rare reports of arrhythmias such as tachycardia, bradycardia, atrioventricular block, and premature ventricular beats.

Gastrointestinal: Constipation, diarrhea, nausea/vomiting, abdominal discomfort/pain, and rare reports of pancreatitis.

Hepatic: There have been occasional reports of hepatocellular, cholestatic, or mixed hepatitis, with or without jaundice. In such circumstances, ranitidine should be immediately discontinued. These events are usually reversible, but in rare circumstances death has occurred. Rare cases of hepatic failure have also been reported. In normal volunteers, SGPT values were increased to at least twice the pretreatment levels in 6 of 12 subjects receiving 100 mg intravenously 4 times daily for 7 days, and in 4 of 24 subjects receiving 50 mg intravenously 4 times daily for 5 days.

Musculoskeletal: Rare reports of arthralgias and myalgias.
Other: Rare cases of hypersensitivity reactions (e.g., bronchospasm, fever, rash, eosinophilia), anaphylaxis, angioneurotic edema, acute interstitial nephritis, and small increases in serum creatinine.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS >>

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj pharmaceuticals API Logo

More Api at Taj Pharmaceuticals Ltd.

Quetiapine Fumarate	Quinine Sulfate	Rabeprazole Sodium	Ramipril	Ranitidine Hydrochloride	Risperidone	Rivastigmine Tartrate	Rizatriptan	Rosiglitazone Maleate	Telmisartan	Tamsulosin HCl
Tegaserod Maleate	Terbinafine HCl	Tolterodine Tartrate	Trandolapril	Valdecoxib	Valsartan	Venlafaxine	Voriconazole	Zolmitriptan	Zonisamide	Primidone

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.